June 29 (Reuters) - Synthetic Biologics Inc :
* SYNTHETIC BIOLOGICS PROVIDES UPDATE ON SYN-020 INTESTINAL ALKALINE PHOSPHATASE PHASE 1 SINGLE-ASCENDING DOSE CLINICAL TRIAL
* SYNTHETIC BIOLOGICS INC - ANALYSES OF PRELIMINARY DATA DEMONSTRATED THAT SYN-020 MAINTAINED A FAVORABLE SAFETY PROFILE, WAS WELL TOLERATED
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
* SYNTHETIC BIOLOGICS PROVIDES UPDATE ON SYN-020 INTESTINAL ALKALINE PHOSPHATASE PHASE 1 SINGLE-ASCENDING DOSE CLINICAL TRIAL
* SYNTHETIC BIOLOGICS INC - ANALYSES OF PRELIMINARY DATA DEMONSTRATED THAT SYN-020 MAINTAINED A FAVORABLE SAFETY PROFILE, WAS WELL TOLERATED
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)